Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Arsenault Kaitlyn Melanie, Chief Financial Officer. Officer active across 1 company, notably Skye Bioscience, Inc.. In total, 1 filings have been recorded. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Kaitlyn Melanie Arsenault serves as Chief Financial Officer at Skye Bioscience, Inc. In this role, she oversees the company's financial operations, ensuring compliance and efficiency in accounting processes. Arsenault plays a key role in financial planning and the company's growth strategy. Her financial expertise is essential for the success of Skye Bioscience.